February 9, 2026
December 16, 2025
In recent years, a concerning trend has emerged in the clinical research industry. Some sponsors and Contract Research Organizations (CROs) are attempting to extend site payments […]
December 11, 2025
This year's SCRS Global Site Solutions Summit celebrated the people and organizations driving clinical research forward. From groundbreaking operational solutions to transformative leadership and measurable impact on patient outcomes, the award recipients represent the best of what collaboration, innovation, and commitment can achieve. These are the organizations and leaders setting the standard for what's possible...
December 10, 2025
For over a decade, Cognizant’s Shared Investigator Platform (SIP) has transformed global clinical research, evolving from a bold vision into a trusted solution that connects thousands of sponsors, sites, and investigators. Today, SIP continues to streamline collaboration, accelerate trials, and enhance transparency to deliver better patient outcomes.
December 10, 2025
Clinical research continues to evolve toward greater connectivity and efficiency, yet study startup remains one of the most complex and time-consuming stages of a trial. Disjointed systems and communication gaps between sponsors, CROs, and research sites often lead to avoidable delays. To address these challenges, Advarra...
December 9, 2025
“It’s incredibly frustrating […] we want technology that actually improves their job”. This was shared in a recent Site Listening Session, but it’s a sentiment I’m sure many can relate to. When tools that are intended to support and accelerate are delivered without their users in mind, it’s a recipe for failure. For sites, every redundant training, missed integration opportunity, and feature that doesn’t quite work as it should, ticks away at the time that could be better spent with patients.
November 20, 2025
The landscape of oncology clinical research is rapidly evolving with the emergence of radiopharmaceutical therapies, also known as radioligand therapy (RLT). These innovative treatments represent a precision medicine approach that uses targeted radiation to treat cancer with a goal of minimizing damage to healthy tissue. However,
October 23, 2025
Direct-to-patient clinical trials are removing traditional barriers to research participation by bringing study activities into patients' homes. Through partnerships that combine virtual site operations with global medication delivery, trials can now reach more diverse populations while reducing travel burdens and accelerating enrollment. Read on to learn how Science 37 and Catalent are making this possible.
October 23, 2025
Cognizant, in collaboration with research KOLs from Australia, delves into the impact of Teletrials in Australia and how these hybrid, decentralized model of trials are bringing novel therapies closer to regional, rural and remote Australians. Teletrials promise to be a global case study on how public health can be promoted at a national level. Download this insightful publication and learn about the steps being taken by Australian Teletrial Program (ATP) to promote teletrials, point of view from Cognizant on how intelligent tech and process alignment can further enhance efficacy of teletrials and real world use cases of teletrials.